# Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** RFA-DK-28-113
- **Status:** forecasted
- **Opens:** November 5, 2026
- **CFDA:** 93.KRP, 93.855
- **View on Kontrakk:** https://kontrakk.com/grants/364219

## Description

No description provided.